OPK-13031

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameOPK-13031
Drug Alias NameAnti-TNF-alpha biologic (TheraKine)OPK-13031
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheraKine Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheraKine Ltd
Active IndicationsN/A
Inactive IndicationsArthritis

Other Information

ATC CodeN/A
Related LinksN/A